Orion Nutraceuticals Inc.
$0.40+0.00%(+$0.00)
TickerSpark Score
43/100
60
Valuation
40
Profitability
60
Growth
24
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORI.CN research report →
52-Week Range50% of range
Low $0.40
Current $0.40
High $0.40
Companywww.orionnutra.ca
Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp.
- CEO
- Joel S. Dumaresq
- IPO
- 2018
- HQ
- Vancouver, BC, CA
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $11.72M
- P/E
- -126.93
- P/S
- 0.00
- P/B
- -10.61
- EV/EBITDA
- -125.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 8.52%
- ROIC
- 8.80%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-61,822 · 77.92%
- EPS
- $-0.00 · 77.89%
- Op Income
- $-316,000
- FCF YoY
- -9.97%
Performance & Tape
- 52W High
- $0.40
- 52W Low
- $0.40
- 50D MA
- $0.40
- 200D MA
- $0.40
- Beta
- -0.14
- Avg Volume
- 0
Get TickerSpark's AI analysis on ORI.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ORI.CN Coverage
We haven't published any research on ORI.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ORI.CN Report →Similar Companies
CNFA.CN+0.00%
CanaFarma Hemp Products Corp.
$0.05
CDX.V-3.85%
Cloud DX Inc.
$0.13
RIV.CN-4.76%
RIV Capital Inc.
$0.10
CHAL.CN+0.00%
Chalice Brands Ltd.
$0.23
KHRN.V+0.00%
Khiron Life Sciences Corp.
$0.04
NVG.CN+0.00%
Nass Valley Gateway Ltd.
$0.04
VIVO.TO+0.00%
VIVO Cannabis Inc.
$0.03
EXM.CN+0.00%
EXMceuticals Inc.
$0.20